×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [3]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Authors
HU YUANJIA [3]
HU HAO [2]
WAN JIANBO [2]
WANG YITAO [1]
CHEN XIN [1]
ZHAO JING [1]
More...
Document Type
Journal article [4]
Book chapter [1]
Date Issued
2022 [1]
2021 [1]
2017 [3]
Language
英語English [5]
Source Publication
MABS [2]
Antibodies [1]
Biosensors and B... [1]
Innovation Value... [1]
Indexed By
SCIE [3]
ESCI [1]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-5 of 5
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Submit date Ascending
Submit date Descending
Issue Date Ascending
Issue Date Descending
Author Ascending
Author Descending
Title Ascending
Title Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method
Journal article
Fu, Shengyu, Zhao, Qi. Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method[J]. Antibodies, 2022, 11(3), 53.
Authors:
Fu, Shengyu
;
Zhao, Qi
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.0
/
4.7
|
Submit date:2022/08/27
Cd22
Elisa
Monoclonal Antibodies
Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients’ plasma
Journal article
Huang,Shengfeng, Tang,Rentao, Zhang,Tingting, Zhao,Jing, Jiang,Zhengjin, Wang,Qiqin. Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients’ plasma[J]. Biosensors and Bioelectronics, 2021, 171(112678).
Authors:
Huang,Shengfeng
;
Tang,Rentao
;
Zhang,Tingting
;
Zhao,Jing
;
Jiang,Zhengjin
; et al.
Favorite
|
TC[WOS]:
24
TC[Scopus]:
25
IF:
10.7
/
9.9
|
Submit date:2021/03/02
Anti-fouling Coating
Poly Adenine
Epitope Mimetic Peptide
Rituximab
Therapeutic Monoclonal Antibodies
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects
Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:135-158
Authors:
Tianhong Yin
;
Xiangjun Kong
;
Yitao Wang
;
Xin Chen
;
Yuanjia Hu
; et al.
Favorite
|
|
Submit date:2019/01/14
Monoclonal Antibodies
Research And Development
Network Analysis
Institutional Collaboration Network
Country-based Collaboration Network
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies
Journal article
Kong, Xiangjun, Wan, Jian-bo, Hu, Hao, Su, Shibing, Hu, Yuanjia. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies[J]. MABS, 2017, 9(7), 1041-1051.
Authors:
Kong, Xiangjun
;
Wan, Jian-bo
;
Hu, Hao
;
Su, Shibing
;
Hu, Yuanjia
Favorite
|
TC[WOS]:
3
TC[Scopus]:
7
IF:
5.6
/
5.8
|
Submit date:2020/05/08
Pharmaceutical Companies
Collaboration Network
Dedicated Biotechnology Firms
Inter-organizational Relationship
Mergers And Acquisitions
Monoclonal Antibodies
Network Evolution
r&d
Technological Innovation
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies
Journal article
Kong, Xiangjun, Wan, Jian-bo, Hu, Hao, Su, Shibing, Hu, Yuanjia. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies[J]. MABS, 2017, 9(7), 1041-1051.
Authors:
Kong, Xiangjun
;
Wan, Jian-bo
;
Hu, Hao
;
Su, Shibing
;
Hu, Yuanjia
Favorite
|
TC[WOS]:
3
TC[Scopus]:
7
IF:
5.6
/
5.8
|
Submit date:2018/10/30
Collaboration Network
Dedicated Biotechnology Firms
Inter-organizational Relationship
Mergers And Acquisitions
Monoclonal Antibodies
Network Evolution
r&d
Pharmaceutical Companies
Technological Innovation